Skip to main content

Featured

Japan Rapidus: ¥920B Funding Fuels 2nm Chip Ambition

Japan is betting ¥920 billion on Rapidus, a semiconductor startup with no manufacturing experience, to challenge incumbent foundry giants. Its mission: achieve high-volume manufacturing of 2-nanometer (2nm) process node technology by 2027—an audacious, almost fantastical goal. ¥920 Billion Cumulative investment in Rapidus 2nm by 2027 Rapidus's manufacturing goal The "Why": A Nation's Bid for a Second Chance Japan, once the 1980s leader in the DRAM market, saw its market share erode due to intense competition from South Korea and a strategic pivot away from high-volume memory production. Decades later, a perfect storm of pandemic-era supply chain disruptions and escalating tech nationalism has forced a dramatic reversal in industrial policy. But Tokyo's strategy isn't just defensive; it's a calculated offensive to re-establish leadership in the semiconductor value chain, built on two core pillars. First is a shift from a defensive po...

US Extends Ebola Ban to Green Card Holders: Rights & Impact

In a stark departure from decades of public health policy, the U.S. government has barred its own lawful permanent residents from re-entry if they have recently been in countries affected by a new Ebola outbreak. The policy, effective May 23, 2026, breaks with the established precedent set during both the 2014 Ebola crisis and the COVID-19 pandemic. During the 2014 outbreak, the U.S. response centered on risk-based screening, funneling travelers from affected nations through five major airports for active symptom monitoring, not blocking their entry. [Source: The White House Archives, Department of Homeland Security]. Similarly, at the height of the COVID-19 pandemic, the expansive Title 42 public health order explicitly exempted U.S. citizens and lawful permanent residents (LPRs) from expulsion, preserving their right to return. [Source: Congressional Research Service, American Immigration Council]. This new ban discards the playbook from both crises, creating an unprecedented barrier for U.S. residents to re-enter their own country.

A Scientifically and Legally Dubious Policy

The Health and Human Services order suspends entry for all non-citizens, including LPRs (Green Card holders), who have been in the Democratic Republic of Congo, Uganda, or South Sudan within the previous 21 days. While the order cites the broad authority of Title 42, Section 265 of the U.S. Code, its application here is incongruent with the established epidemiology and transmission dynamics of the virus it aims to contain. [Source: U.S. Code, Title 42].

Public health bodies like the WHO and CDC have long established that Ebola is not airborne and is transmitted via direct contact with the bodily fluids of a symptomatic person, with a predictable incubation period of up to 21 days. [Source: World Health Organization, CDC]. These scientific facts are precisely what made the 2014 risk-based screening and active monitoring protocols a successful and proportionate response. By ignoring this proven, less-restrictive strategy in favor of a categorical entry suspension, the new policy uses a broad legal authority to enforce a measure that is scientifically unnecessary and contrary to the public health consensus that travel bans are often counterproductive, as they can drive outbreaks underground and impede international aid. [Source: CDC]. The result is a policy that treats established U.S. residents—who pay taxes, own homes, and raise families here—identically to temporary tourists, effectively nullifying their right of re-entry.

For lawful permanent residents with family or business in the affected regions, this policy creates an impossible choice: fulfill essential travel obligations and risk being locked out of their American lives indefinitely, or abandon those ties completely. This effectively places their careers, family connections, and property in the U.S. in legal and financial jeopardy.

Sources & References
Related Articles

Comments